You are here

Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study

Last updated on March 11, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Torino, , 10128 Italy
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Rheumatoid Arthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Eighteen years of age or older with diagnosis of RA based on the 1987 American College
of Rheumatology (ACR) criteria and in accordance with local guidelines.

- Patients eligible to anti-TNF therapy

- Patients naïve to anti-TNFa drugs

- Patients with radiography (hands and feet) executed by 6 months before the baseline or
at baseline according to modified Sharp Van der Hejde method [Sharp JT et al. 1985;
Sharp JT. Et al. 1989; Van der Heijde DM et al. 1989] Patients capable of
understanding and completing the questionnaire Patients capable of understanding and
signing an informed consent form

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients with tumors

- Patients already included in clinical trials

NCT00793403
Pfizer
Completed
Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Crohn Desease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
NCT02925338
All Genders
6+
Years
Multiple Sites
Systemic Lupus Erythematosus, Rheumatoid Arthritis
NCT03334851
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now